Uchino Gaku, Murakami Hirohisa, Mukohara Nobuhiko, Tanaka Hiroshi, Nomura Yoshikatsu, Miyahara Shunsuke
Department of Cardiovascular Surgery, Hyogo Brain and Heart Center, Himeji, Hyogo, Japan.
Thorac Cardiovasc Surg. 2023 Sep;71(6):441-447. doi: 10.1055/s-0042-1750038. Epub 2022 Jul 11.
This study aimed to compare the short- and long-term outcomes of saphenous vein grafts (SVGs) and in situ left internal thoracic artery (LITA) grafts to the left circumflex artery (LCX) territory.
This study included 678 patients who underwent LITA-left anterior descending (LAD) + SVG-LCX grafts and 286 patients who underwent right internal thoracic artery (RITA)-LAD + in situ LITA-LCX grafts from January 2002 to December 2020. Short-term and long-term clinical outcomes were compared using inverse probability of treatment weighting adjustment to reduce selection bias.
In-hospital mortality was significantly higher for the SVG-LCX group ( = 0.008), whereas deep sternal wound infection was significantly higher in the LITA-LCX group ( = 0.013).Survival rates at 5 and 10 years were 83.12 and 71.45% in the SVG-LCX group, whereas 75.24 and 65.54% in the LITA-LCX group (log-rank = 0.114). Rates of freedom from cardiac events at 5 and 10 years were 92.82 and 85.24% in the SVG-LCX group, whereas 94.89 and 89.46% in the LITA-LCX group (log-rank = 0.179).Univariate and multivariate logistic regression analysis showed that proximal severe stenosis was significantly protective against graft dysfunction before discharge (odds ratio, 0.43; 95% confidence interval, 0.23-0.81).
Deep sternal wound infection was significantly higher for LITA to LCX bypass whereas in-hospital mortality was higher for SVG to LCX. In situ LITA to LCX bypass grafting exhibited similar long-term outcomes with SVG to LCX bypass grafting in adjusted patient cohorts. Proximal severe stenosis of LCX was protective against graft dysfunction.
本研究旨在比较大隐静脉移植血管(SVG)和原位左内乳动脉(LITA)移植至左旋支动脉(LCX)区域的短期和长期结果。
本研究纳入了2002年1月至2020年12月期间接受LITA-左前降支(LAD)+SVG-LCX移植的678例患者以及接受右内乳动脉(RITA)-LAD+原位LITA-LCX移植的286例患者。采用治疗权重逆概率调整比较短期和长期临床结果,以减少选择偏倚。
SVG-LCX组的住院死亡率显著更高(P=0.008),而LITA-LCX组的深部胸骨伤口感染显著更高(P=0.013)。SVG-LCX组5年和10年生存率分别为83.12%和71.45%,而LITA-LCX组分别为75.24%和65.54%(对数秩检验P=0.114)。SVG-LCX组5年和10年无心脏事件发生率分别为92.82%和85.24%,而LITA-LCX组分别为94.89%和89.46%(对数秩检验P=0.179)。单因素和多因素逻辑回归分析显示,近端严重狭窄对出院前移植血管功能障碍具有显著保护作用(比值比,0.43;95%置信区间,0.23-0.81)。
LITA至LCX搭桥的深部胸骨伤口感染显著更高,而SVG至LCX的住院死亡率更高。在调整后的患者队列中,原位LITA至LCX搭桥移植与SVG至LCX搭桥移植的长期结果相似。LCX近端严重狭窄对移植血管功能障碍具有保护作用。